The Maryland Thoroughbred Horsemen’s Association has released a statement regarding the use of anti-bleeding medications for racehorses in training. Horsemen are encouraged to stop the use of these drugs immediately, particularly the use of aminocaproic acid, sold under the name Amicar.
Amicar and other anti-bleeding medications are used to prevent bleeding from horses that suffer from Exercise Induced Pulmonary Hemorrhage (EIPH).
Amicar and multiple other anti-bleeding medications were placed on the Prohibited List in 2013 under Association of Racing Commissioners International Uniform Classification Guidelines for Foreign Substances.
These medications were placed on this list because they cannot be regulated by withdrawal time guidelines, and the medications have no timeline in which they can be used in which they might not trigger a positive test post-race.
Any trainer who uses these medications runs the risk of his or her horse coming back with a positive drug test post-race.
Read more here.
New to the Paulick Report? Click here to sign up for our daily email newsletter to keep up on this and other stories happening in the Thoroughbred industry.
Copyright © 2021 Paulick Report.